PDS Biotech prices up to USD 22.55 million PIPE led by Nant Capital

Reuters2026/09/08 12:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

PDS Biotech announced a PIPE financing of up to USD 22.55 million led by Nant Capital, with additional participation from existing investors.
Initial closing targets about USD 11.55 million around Sept. 11, 2026, via unregistered common stock or pre-funded warrants with common warrants.
Units priced at USD 0.28 per share unit or USD 0.28 per pre-funded unit.
Milestone closing would add USD 11 million if a registrational Phase 3 PDS0301 protocol is submitted to the FDA in collaboration with Nant.
Nant can appoint two directors if it owns at least 15%, including Patrick Soon-Shiong; proceeds earmarked for debt repayment, R&D, working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PDS Biotechnology Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609080830PRIMZONEFULLFEED9822558) on September 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

PDS Biotech prices up to USD 22.55 million PIPE led by Nant Capital

You may also like

Crypto prices